首页> 外国专利> HIV related peptide immunogenic antigens and use thereof as subunit vaccine for AIDS virus

HIV related peptide immunogenic antigens and use thereof as subunit vaccine for AIDS virus

机译:HIV相关肽免疫原性抗原及其作为AIDS病毒亚单位疫苗的用途

摘要

Vaccines effective in the inhibition of infection caused by the family of retroviruses, HTLV-III, Human T-cell Leukemia Virus, LAV, Lymphadenopathy-associated virus, ARV-2, AIDS-Related Virus, (AIDS and AIDS-Related Complex) have been developed from an antisera prepared against thymosin alpha 1 (T alpha 1), a thymic hormone, as well as from antisera to synthetic peptide fragments of T alpha 1 and antisera to synthetic peptide fragments inclusive of amino acid positions 92-109 of the p17 gag core protein of HTLV-III, LAV and ARV-2. In this 18 amino acid primary sequence there is a 44 to 50% homology between the gag protein and T alpha 1. Immunoglobulin (IgC)-enriched preparations of the T alpha 1 antisera have enhanced activity in blocking viral replication. A diagnostic test capable of directly detecting the presence of HTLV-III, LAV, ARV-2 and related retroviruses associated with AIDS and ARC is also described.
机译:有效抑制由逆转录病毒家族,HTLV-III,人类T细胞白血病病毒,LAV,淋巴结病相关病毒,ARV-2,艾滋病相关病毒(与艾滋病相关的复合物)引起的感染的疫苗从针对胸腺素胸腺素α1(T alpha 1)制备的抗血清以及从抗血清到Tα1的合成肽片段以及从抗血清到包括p17氨基酸92-109位的合成肽片段开发而成HTLV-III,LAV和ARV-2的gag核心蛋白。在这18个氨基酸的一级序列中,gag蛋白和T alpha 1之间有44%到50%的同源性。富含免疫球蛋白(IgC)的T alpha 1抗血清制剂在阻断病毒复制中具有增强的活性。还描述了一种诊断测试,该测试能够直接检测HTLV-III,LAV,ARV-2和与AIDS和ARC相关的相关逆转录病毒的存在。

著录项

  • 公开/公告号PH26239A

    专利类型

  • 公开/公告日1992-04-01

    原文格式PDF

  • 申请/专利权人 VIRAL TECHNOLOGIES INC.;

    申请/专利号PH19710000352

  • 发明设计人 ALLAN L GOLDSTEIN;SU SUN WANG;

    申请日1987-05-19

  • 分类号A61K39/12;A61K37/00;C07K7/08;C07K7/10;C07K17/08;

  • 国家 PH

  • 入库时间 2022-08-22 05:34:03

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号